1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Markers

Cancer Markers

  • March 2016
  • -
  • Kalorama Information
  • -
  • 155 pages

Summary

Table of Contents

Search Inside

Cancer is the number two cause of death, behind only cardiovascular disease. The most common types of cancer worldwide include breast cancer, colorectal cancer, lung cancer, and prostate cancer. For these and other types of cancer, novel biomarkers, therapies, and diagnostic tests are being developed. Cancer Markers provides market assessment, estimate and competitive analysis for tests for oncology that use biomarkers. This includes a range of technologies made by scores of companies. The report contains products designed to determine risk for cancer, screen for cancer, test for cancer, aid in prognosis and personalize therapy. Among the technologies are the following:

Histology/Cytology:
Immunohistochemistry
In situ hybridization
Immunoassays - Tumor Markers:
Flow Cytometry
Rapid Tests:
Molecular Marker-Based

Estimates for these segments are provided for 2015 and 2020. In addition, some specific marker breakouts are provided along with significant detail of products on the market. This report reviews the progression of cancer diagnostic technologies over the past 10-15 years and notes some trends in test strategies as well.

Cancer Markers provides the following data:
Worldwide Cancer Biomarkers Diagnostic Market - 2015 and 2020 (IHC, ISH, Immunoassays, Flow, Rapid, Molecular)
Selected International Agreements
Worldwide Cancer Biomarkers Diagnostic Market Percentage (IHC, ISH, Flow Cytometry, Molecular-Based Assays, NMP22, FOB, PSA, CEA, CA125, AFP, Other Tumor Markers)
Estimated Global Incidence and Mortality due to Cancer, 2012 - By Regions of the World
Selected Widely Used Tumor Markers
Selected Biomarkers and Biomarker Panels to Assess Risk of Cancer, and Companies Developing/Marketing These Biomarkers
Selected Biomarkers and Biomarker Panels for Cancer Screening, and Companies Developing/Marketing These Biomarkers
Selected Biomarkers and Biomarker Panels for Diagnosis and/or Monitoring of Cancer, and Companies Developing/Marketing These Biomarkers
Selected Biomarkers and Biomarker Panels to Predict Prognosis of Cancer, and Companies Developing/Marketing These Biomarkers
Selected Biomarkers and Biomarker Panels to Predict Response to Therapy, and Companies Developing/Marketing These Biomarkers
Selected FDA Cleared/Approved Companion Diagnostic Tests, and Companies Developing/Marketing These Biomarkers
Selected Companies Developing/Marketing Cancer Tests
Common Next Generation Molecular Test Traits
Selected Sample Preparation Reagents
Selected Cancer Test Innovations, 2015

This report contains company profiles, including coverage of the following:
Abbott Laboratories
Alere Inc. (Abbott)
bioMerieux SA
Hologic, Inc.
Illumina, Inc.
QIAGEN N.V.
Roche
Thermo Fisher Scientific, Inc.

The information presented in this report is derived on publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and interviews with industry professionals and experts in the areas of in vitro diagnostics and personalized medicine.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected ...

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Analyze the global prostate cancer market, with important statistics and analysis on existing drugs, and diagnostic technologies. - Receive information on regulatory environment, ...

Prostate Cancer Therapeutics Market ; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Prostate Cancer Therapeutics Market ; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • March 2017
  • by Transparency Market Research

Global Prostate Cancer Therapeutics Market: Overview This report on the prostate cancer therapeutics market analyzes the current and future scenario of the global market. Increasing prevalence of prostate ...


Download Unlimited Documents from Trusted Public Sources

Endocrine Disease Statistics in the US

  • April 2017
    122 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Cancer Statistics - Forecast

  • April 2017
    10 pages
  • Cancer  

  • Europe  

    United Kingdom  

    United States  

View report >

Cancer Statistics in the US

  • April 2017
    24 pages
  • Cancer  

    Healthcare Fina...  

  • United States  

View report >

Leukemia Statistics

10 days ago

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.